EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol improves non-motor symptoms, attenuates neuroinflammation, and favours hippocampal newborn neuronal maturation in a rat model of Parkinsonism

Bianca Andretto de Mattos, Jéssica Mendes Bonato, Maria Clara Splendor, Elaine Del Bel, Humberto Milani, Rúbia Maria Weffort de Oliveira iD

Acta Neuropsychiatrica · 2024

DOI: 10.1017/neu.2024.15 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropsychiatrica, 2024. Verfasst von Bianca Andretto de Mattos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, State University of Maringá, Maringá, Paraná, Brazil. Hauptthemen laut MEDLINE: Cannabidiol, Hippocampus, Rats, Wistar, Parkinsonian Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the effects of cannabidiol (CBD) on emotional and cognitive symptoms in rats with intra-nigral 6-hydroxydopamine (6-OHDA) lesions.

Methods

Adult male Wistar rats received bilateral intranigral 6-OHDA infusions and were tested in a battery of behavioural paradigms to evaluate non-motor symptoms. The brains were obtained to evaluate the effects of CBD on hippocampal neurogenesis.

Results

6-OHDA-lesioned rats exhibited memory impairments and despair-like behaviour in the novelty-suppressed feeding test and forced swim test, respectively. The animals also exhibited dopaminergic neuronal loss in the substantia nigra pars compacta (SNpc), striatum, and ventral tegmental area and a reduction of hippocampal neurogenesis. CBD decreased dopaminergic neuronal loss in the SNpc, reduced the mortality rate and decreased neuroinflammation in 6-OHDA-lesioned rats. In parallel, CBD prevented memory impairments and attenuated despair-like behaviour that were induced by bilateral intranigral 6-OHDA lesions. Repeated treatment with CBD favoured the neuronal maturation of newborn neurons in the hippocampus in Parkinsonian rats.

Conclusion

The present findings suggest a potential beneficial effect of CBD on non-motor symptoms induced by intra-nigral 6-OHDA infusion in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolHippocampusRats, WistarParkinsonian DisordersOxidopamineNeurogenesisDisease Models, AnimalAnimalsMaleRatsDopaminergic NeuronsNeuroinflammatory DiseasesMemory DisordersNeuronsBehavior, Animal

Stichwörter der Autor:innen

6-OHDA lesioncannabidiolhippocampalmemoryneurogenesisneuroinflammation

Substanzen

CannabidiolOxidopamine

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, State University of Maringá, Maringá, Paraná, Brazil.
  • Department of Basic and Oral Biology, School of Medicine, USP, Ribeirão Preto, São Paulo, Brazil.

ORCID-Profile: Rúbia Maria Weffort de Oliveira

Zitieren

APA

de Mattos, B. A., Bonato, J. M., Splendor, M. C., Del Bel, E., Milani, H., & de Oliveira, R. M. W. (2024). Cannabidiol improves non-motor symptoms, attenuates neuroinflammation, and favours hippocampal newborn neuronal maturation in a rat model of Parkinsonism. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2024.15

Vancouver

de Mattos BA, Bonato JM, Splendor MC, Del Bel E, Milani H, de Oliveira RMW. Cannabidiol improves non-motor symptoms, attenuates neuroinflammation, and favours hippocampal newborn neuronal maturation in a rat model of Parkinsonism. Acta Neuropsychiatrica. 2024. doi:10.1017/neu.2024.15

BibTeX
@article{deMattos2024,
  author = {de Mattos, Bianca Andretto and Bonato, Jéssica Mendes and Splendor, Maria Clara and Del Bel, Elaine and Milani, Humberto and de Oliveira, Rúbia Maria Weffort},
  title = {Cannabidiol improves non-motor symptoms, attenuates neuroinflammation, and favours hippocampal newborn neuronal maturation in a rat model of Parkinsonism},
  journal = {Acta Neuropsychiatrica},
  year = {2024},
  doi = {10.1017/neu.2024.15}
}
Kostenlos starten →